Cite
Quantitative analysis of CDKN2A methylation, mRNA, and p16(INK4a) protein expression in children and adolescents with Burkitt lymphoma: biological and clinical implications.
MLA
Robaina, Marcela Cristina S., et al. “Quantitative Analysis of CDKN2A Methylation, MRNA, and P16(INK4a) Protein Expression in Children and Adolescents with Burkitt Lymphoma: Biological and Clinical Implications.” Leukemia Research, vol. 39, no. 2, Feb. 2015, pp. 248–56. EBSCOhost, https://doi.org/10.1016/j.leukres.2014.11.023.
APA
Robaina, M. C. S., Faccion, R. S., Arruda, V. O., de Rezende, L. M. M., Vasconcelos, G. M., Apa, A. G., Bacchi, C. E., & Klumb, C. E. (2015). Quantitative analysis of CDKN2A methylation, mRNA, and p16(INK4a) protein expression in children and adolescents with Burkitt lymphoma: biological and clinical implications. Leukemia Research, 39(2), 248–256. https://doi.org/10.1016/j.leukres.2014.11.023
Chicago
Robaina, Marcela Cristina S, Roberta Soares Faccion, Viviane Oliveira Arruda, Lidia Maria Magalhães de Rezende, Gisele Moledo Vasconcelos, Alexandre Gustavo Apa, Carlos E Bacchi, and Claudete Esteves Klumb. 2015. “Quantitative Analysis of CDKN2A Methylation, MRNA, and P16(INK4a) Protein Expression in Children and Adolescents with Burkitt Lymphoma: Biological and Clinical Implications.” Leukemia Research 39 (2): 248–56. doi:10.1016/j.leukres.2014.11.023.